COPD. Chronic obstructive pulmonary disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, in addition to the standard pharmacological therapy consisting of a long-acting beta-agonist (LABA) and a long-acting anticholinergic age
Nafas Zist Pharmed Co., Iran).Alongside these medications, participants in this group will undergo one session of traditional phlebotomy (Fasd) performed by the researcher on the brachial vein—prefera
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Patients have stable conditions. (It means that vital signs such as blood pressure, heart rate, temperature and breathing rate are mentioned in the normal range, which will preferably be mentioned later). 2) The patient's symptoms have been stable for at least the last two weeks. 3) There is a willingness and consent of the person to enter the study. 4) The hemoglobin level is 14-18 grams per deciliter.
Exclusion criteria
Exclusion criteria: 1) Patients with a history of anemia (hemoglobin less than 13) 2) Patients with a history of coagulation disorder or use of chemical anticoagulants, such as warfarin, etc., or continuous use of herbal medicines such as warfarin and ginger, chamomile, thyme, etc. 3) Performing fasd or cupping less than a month ago 4) Patients with severe COPD and requiring hospitalization 5) Patients with underlying diseases such as autoimmune diseases requiring the use of corticosteroids or other immunomodulatory drugs such as rheumatoid arthritis, etc. or underlying lung diseases such as cystic fibrosis CF, bronchopulmonary dysplasia , heart failure, bronchotracheomalacia, bronchiectasis, pulmonary embolism and sarcoidosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of quality of life of patients. Timepoint: in first visit: FSD + CAT questionnaire + general patient information form and Dr. Salman Nejad's questionnaire_Second telephone visit one day later: CAT questionnaire and questions about possible complications + symptom checklist_Third telephone visit one week later: CAT questionnaire and questions about possible complications + symptom checklist_Fourth in-person visit one month later: CAT questionnaire + symptom checklist. Method of measurement: COPD Assessment Test (CAT) Questionnair. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmandana afsharipour
Shahid Beheshti University of Medical Sciences
Outcome results
None listed